Man Group plc

Position in VCEL — Vericel Corp

CIK 1637460 LONDON, X0

Position in VCEL

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,240,415

+$1,347,764 QoQ

Shares Held

69,643

+180.9% QoQ

Ownership

0.136%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

10 quarters on record

Voting authority Sole 94.47754978964146.ToString("F0")% Shared 0.ToString("F0")% None 5.522450210358542.ToString("F0")%

Healthcare · as of Mar 31, 2026

Man Group plc holds $1,080,100,046 across 125 Biotechnology names. VCEL ranks #48 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	315,212	$243,545,399
2	VRTX	Vertex Pharmaceuticals Inc / Ma	236,798	$105,739,778
3	INCY	Incyte Corp	930,171	$87,547,693
4	ALNY	Alnylam Pharmaceuticals, Inc.	232,369	$76,883,931
5	ONC	BeOne Medicines Ltd.	241,922	$71,843,576
6	APLS	Apellis Pharmaceuticals, Inc.	915,689	$36,838,167
7	RVMD	Revolution Medicines, Inc.	275,270	$26,770,006
8	JAZZ	Jazz Pharmaceuticals plc	135,212	$25,561,828

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,240,415	69,643	+180.9%	Shares	Defined	2026-05-15
2025-12-31	$892,651	24,789	+84.8%	Shares	Defined	2026-02-17
2024-09-30	$566,867	13,417	-82.1%	Shares	Defined	2024-11-14
2024-06-30	$3,442,468	75,032	-26.6%	Shares	Defined	2024-08-14
2024-03-31	$5,317,952	102,229	-34.2%	Shares	Defined	2024-05-15
2023-12-31	$5,530,233	155,300	+38.2%	Shares	Defined	2024-02-14
2023-09-30	$3,767,648	112,400	+288.9%	Principal	Defined	2023-11-14
2023-06-30	$1,085,773	28,900	-42.0%	Shares	Defined	2023-08-14
2023-03-31	$1,460,136	49,800	+146.5%	Principal	Defined	2023-05-15
2020-12-31	$623,776	20,200	—	Shares	Defined	2021-02-16
No filing history on record for this holder in this stock.